Congenital disorder of glycosylation type Ia (CDG-Ia): phenotypic spectrum of the R141H/F119L genotype

被引:66
作者
Kjaergaard, S [1 ]
Schwartz, M [1 ]
Skovby, F [1 ]
机构
[1] Univ Hosp, Dept Clin Genet, Rigshosp 4062, DK-2100 Copenhagen, Denmark
关键词
congenital disorder of glycosylation type Ia; phenotype; phosphomannomutase deficiency;
D O I
10.1136/adc.85.3.236
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aims-To delineate common and variable features and outcome of children with congenital disorder of glycosylation type Ia (CDG-Ia) caused by the frequent R141H/F119L PMM2 genotype. Methods-Clinical data on 25 patients (mean age 7.6 years, range 0-19) were analysed. Results-All patients had an early presentation with severe feeding problems and failure to thrive, hypotonia, hepatic dysfunction, inverted nipples, and abnormal subcutaneous fat pads. Eighteen patients were hospitalised in the neonatal period. Developmental delay was obvious before age 6 months. During the first seven months mean standard deviation score (SDS) for weight and length decreased 2.7 (SD = 2) and 2.4 (SD = 2), respectively. Mental retardation, ataxia, muscular atrophy, and febrile seizures were consistent features after infancy. Variable features included pericardial effusions, afebrile seizures, and stroke like episodes. Computed tomography/magnetic resonance imaging of the brain was normal in two patients examined before 4 months of age, but 18 children examined after 3 months of age had cerebellar atrophy, and 10 children also had supratentorial atrophy. Subsequent imaging showed progression of the cerebellar and supratentorial atrophy in eight and four of 10 children, respectively. Mean head circumference SDS declined from zero to -1.9 SD from age 3 months to 5 years. Motor ability ranged from none to walking with a rolator, and vocabulary ranged from none to comprehensible speech. The overall mortality ascribed to CDG-Ia was 18%. Conclusion-Patients with the R141H/F119L genotype have an early uniform presentation including severe failure to thrive, but their functional outcome is variable. This genotype may well cause clinical manifestations in the severe end of the spectrum of CDG-Ia.
引用
收藏
页码:236 / 239
页数:4
相关论文
共 24 条
[1]  
Andersen E, 1982, Ugeskr Laeger, V144, P1760
[2]   Developmental patterns and neuropsychological assessment in patients with carbohydrate-deficient glycoconjugate syndrome type IA (phosphomannomutase deficiency) [J].
Barone, R ;
Pavone, L ;
Fiumara, A ;
Bianchini, R ;
Jaeken, J .
BRAIN & DEVELOPMENT, 1999, 21 (04) :260-263
[3]   Detailed mapping of the phosphomannomutase 2 (PMM2) gene and mutation detection enable improved analysis for Scandinavian CDG type I families [J].
Bjursell, C ;
Wahlström, J ;
Berg, K ;
Stibler, H ;
Kristiansson, B ;
Matthijs, G ;
Martinsson, T .
EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 (06) :603-611
[4]   A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases [J].
de Lonlay, P ;
Seta, N ;
Barrot, S ;
Chabrol, B ;
Drouin, V ;
Gabriel, BM ;
Journel, H ;
Kretz, M ;
Laurent, J ;
Le Merrer, M ;
Leroy, A ;
Pedespan, D ;
Sarda, P ;
Villeneuve, N ;
Schmitz, J ;
van Schaftingen, E ;
Matthijs, G ;
Jaeken, J ;
Korner, C ;
Munnich, A ;
Saudubray, JM ;
Cormier-Daire, V .
JOURNAL OF MEDICAL GENETICS, 2001, 38 (01) :14-19
[5]  
DEZEGHER F, 1995, PEDIATR RES, V37, P396
[6]  
Farkas L.G., 1981, ANTHROPOMETRY HEAD F
[7]  
HAGBERG BA, 1996, HAND CLINIC, P623
[8]   OLIVOPONTOCEREBELLAR ATROPHY OF NEONATAL ONSET AND DISIALOTRANSFERRIN DEVELOPMENT DEFICIENCY SYNDROME [J].
HORSLEN, SP ;
CLAYTON, PT ;
HARDING, BN ;
HALL, NA ;
KEIR, G ;
WINCHESTER, B .
ARCHIVES OF DISEASE IN CHILDHOOD, 1991, 66 (09) :1027-1032
[9]   Genotypes and phenotypes of patients in the UK with carbohydrate-deficient glycoprotein syndrome type 1 [J].
Imtiaz, F ;
Worthington, V ;
Champion, M ;
Beesley, C ;
Charlwood, J ;
Clayton, P ;
Keir, G ;
Mian, N ;
Winchester, B .
JOURNAL OF INHERITED METABOLIC DISEASE, 2000, 23 (02) :162-174
[10]  
Jaeken J, 1991, Acta Paediatr Scand Suppl, V375, P1